OR WAIT null SECS
May 03, 2023
The use of smart tools in early drug discovery can have an impact on downstream phases of drug development.
April 02, 2023
Decreasing vein to vein time saves lives.
March 01, 2023
Key challenges posed to autologous and allogeneic treatments could be resolved by in-vivo CAR-T gene therapies.
February 02, 2023
In vivo CAR-T gene therapies could resolve challenges faced by autologous and allogeneic treatments.
December 03, 2022
Although well known in R&D, PK/PD studies are an equally powerful tool for promoting successful biologic drug development.
November 02, 2022
Experts discuss factors that can affect the outcome of an ADME study, signs that a drug compound shows promise, red flags, and key parameters to determine safety and efficacy.
October 16, 2022
An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.
September 06, 2022
How Pfizer’s external-facing research and development scientists uncover the most promising emerging therapy concepts and ideas in the pharmaceutical landscape.
June 13, 2022
Precision BioSciences has released clinical trial data on CAR T therapy candidates PBCAR0191, PBCAR19B, and PBCAR269A.
June 03, 2022
Collecting relevant data, planning ahead, and communicating with regulatory bodies in pre-IND meeting programs can help companies to avoid roadblocks in IND applications.